James Lee, MD
Family Medicine · West Sacramento, CANPI 1366476970
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 271 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,650 and has fallen 89.9% since, to $167 in 2025. Among family medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$648
- AstraZeneca$567
- Novo Nordisk$550
- Lilly USA, LLC$506
- Bayer$344
- Pfizer$315
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,922100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 27 | $648 |
| AstraZeneca | 36 | $567 |
| Novo Nordisk | 26 | $550 |
| Lilly USA, LLC | 37 | $506 |
| Bayer | 15 | $344 |
| Pfizer | 25 | $315 |
| Sanofi-aventis U.S. LLC | 17 | $263 |
| Boehringer Ingelheim | 9 | $206 |
| Biohaven Pharmaceuticals, Inc. | 10 | $187 |
| Abbott | 9 | $178 |
| GSK | 9 | $172 |
| Merck | 9 | $167 |
| AbbVie(2 entities) | 6 | $149 |
| Amarin Pharma, Inc. | 7 | $124 |
| Hologic Sales And Service, LLC | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 5 | $77 |
| Amgen | 3 | $75 |
| Intra-sana Laboratories | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| UCB, Inc. | 1 | $34 |
| Boston Scientific | 1 | $26 |
| Medtronic | 1 | $24 |
| Sanofi Pasteur Inc. | 2 | $23 |
| Forte Bio-pharma LLC | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| RGH Enterprises LLC | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Gilead | 1 | $16 |
| Cranial Technologies, Inc | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,927 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 51 | $49,563 |
| JanuviaSitagliptin Phosphate | 33 | $34,288 |
| EliquisApixaban | 19 | $20,723 |
| JardianceEmpagliflozin | 24 | $20,713 |
| MounjaroTirzepatide | 13 | $13,522 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $12,832 |
| XareltoRivaroxaban | 11 | $11,568 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 33 | $6,771 |
| FarxigaDapagliflozin Propanediol | 12 | $6,012 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 185 | $5,187 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $5,129 |
| DuleraMometasone/Formoterol | 11 | $4,994 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 19 | $4,812 |
| Atorvastatin Calcium | 351 | $3,648 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $3,252 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $506 | $63,08564 claims |
| MerckJanuvia, Dulera | $167 | $39,28244 claims |
| PfizerEliquis | $315 | $20,72319 claims |
| Boehringer IngelheimJardiance | $206 | $20,71324 claims |
| GSKTrelegy Ellipta, Shingrix | $172 | $19,60350 claims |
| Johnson & JohnsonXarelto | $648 | $11,56811 claims |
| AstraZenecaFarxiga, Symbicort | $567 | $11,14123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in West Sacramento
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.